Zurueck zur Suche

Reporte zur Charge UJ702AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

15Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MA 3 PA 3 NY 2 NJ 1 AK 1 OH 1 IL 1 CA 1 HI 1

VAERS 1675096

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge Uj702aa

schwer
Staat
NY
Alter
67,0
Geschlecht
F
Eingang
05.09.2021
Impfdatum
04.09.2021
Beginn
04.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood glucose decreased Condition aggravated Fatigue Nausea Seizure Vomiting

Symptomtext

Patient reports experiencing extreme fatigue, nausea/vomiting, low blood sugar (diabetic), and seizure (history of seizures) about 2 hours after receiving the vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
None at this time. I instructed the patient to contact her primary care doctor as soon as possible.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
COPD, GERD, type 2 diabetes, hypertension
Andere Medikamente
Losartan 100 mg, Symbicort 160/4.5 inhaler, clonidine 0.2 mg, glyburide 5 mg, omeprazole 40 mg, amlodipine 10 mg, metoprolol succinate 25 mg, paroxetine 10 mg
Allergien
Yellow dye, blue dye, red dye
Vorherige Impfungen
-

VAERS 1840395

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj702aa

mild
Staat
NY
Alter
85,0
Geschlecht
F
Eingang
03.11.2021
Impfdatum
08.10.2021
Beginn
10.10.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Product administered at inappropriate site Rotator cuff syndrome

Symptomtext

shoulder pain and believes the vaccine was given too high on the arm. went to the hospital to get checked and md believes it is a rotator arm injury

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
chronic ischemic heart disease; hypertension; vertigo
Andere Medikamente
n/a
Allergien
none known
Vorherige Impfungen
-

VAERS 1785260

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge uj702aa

mild
Staat
MA
Alter
72,0
Geschlecht
F
Eingang
14.10.2021
Impfdatum
08.10.2021
Beginn
08.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cardiac disorder Heart rate decreased Injection site pain

Symptomtext

Site: Pain at Injection Site-Mild, Systemic: Cardiac Disorder (diagnosed by MD)-Severe, Systemic: low heart rate-Severe

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1741266

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

mild
Staat
NJ
Alter
67,0
Geschlecht
F
Eingang
28.09.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Back pain Chills Gait disturbance Headache Hyperhidrosis Injection site pain Myalgia Nausea Pain Rhinorrhoea Sinus congestion

Symptomtext

1. Extreme soreness at injection site, still slightly sore 2 weeks later 2. Severe, shooting, pains on left side of right knee making it difficult to walk. This pain comes and goes where I can't walk. It's 2 weeks and that spot on my right knee is still tender 3. nauseous 4. Severe headaches for 3 days 5. slight chills and sweats at night 6. Severe back pains for 3 days 7. Overall muscle and joint aches for 2 weeks 8. Sinus congestion and runny nose I took over the counter decongestants, Tylenol, used heating pads and ice packs, I emailed my physician and he said the symptoms should burn out in time

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Celiac disease, ruptured tendon of left ring finger, Lyme
Vorgeschichte
Celiac disease, supragastric belching, Post lyme hypersensitivity, rapid transit, low peristalsis pressure
Andere Medikamente
Vitamins C, D, Lutein, Calcium Citrate, Magnesium, fish oil, Refresh Optive Mega-3 eye drops Biotin
Allergien
gluten, Reglan, Baclofen, sulfa drugs, sulfites, sulfates, Doxycycline, Flagyl, Cipro, Codeine, Cortisone ointments, Betamethasone, wool, lanolin, aloe, ducal temporary dental cement
Vorherige Impfungen
Prevnar 23 age 65 cellulitis of arm, Zoster 58 mild case of shingles on my left arm, muscle and joint aches, headaches 3 weeks;

VAERS 1723075

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

mild
Staat
AK
Alter
85,0
Geschlecht
M
Eingang
22.09.2021
Impfdatum
08.09.2021
Beginn
08.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity Shoulder injury related to vaccine administration

Symptomtext

Patient came by a few days after getting his flu shot and complained he was still having arm pain and it was recommended to him to take ibuprofen. Patient came back by the pharmacy on 9/21/21 and said he was still having pain in his arm that was not getting any better and said he has made an appointment to see his physician. Suspected that patient may have SIRVA.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown. fills medications at another pharmacy
Allergien
none
Vorherige Impfungen
-

VAERS 1706845

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ702AA

mild
Staat
MA
Alter
70,0
Geschlecht
F
Eingang
17.09.2021
Impfdatum
31.08.2021
Beginn
02.08.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Body temperature Chills Feeling hot Interchange of vaccine products Pyrexia Vaccination site pain

Symptomtext

Dose 1 and 2 Pfizer, Dose 3 Moderna; Felt warm briefly but drank water and that went away; Injection site hurt; Slight chills; Temp of 100.1 F/ The toilet seat felt extra cool which probably means I was running a temperature; Mild chills for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Dose 1 and 2 Pfizer, Dose 3 Moderna), FEELING HOT (Felt warm briefly but drank water and that went away), VACCINATION SITE PAIN (Injection site hurt), CHILLS (Slight chills) and PYREXIA (Temp of 100.1 F/ The toilet seat felt extra cool which probably means I was running a temperature) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product INFLUENZA VACCINE (FLU SYRINGE) for an unknown indication. Previously administered products included for an unreported indication: PFIZER BIONTECH COVID-19 VACCINE (First dose on 09-Feb-2021 and the second on 02-Mar-2021) on 09-Feb-2021. On 31-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (FLU SYRINGE) (unknown route) 1 dosage form. On 02-Aug-2021, the patient experienced CHILLS (Mild chills for 2 days). On 31-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Dose 1 and 2 Pfizer, Dose 3 Moderna), FEELING HOT (Felt warm briefly but drank water and that went away), VACCINATION SITE PAIN (Injection site hurt), CHILLS (Slight chills) and PYREXIA (Temp of 100.1 F/ The toilet seat felt extra cool which probably means I was running a temperature). On 31-Aug-2021, INTERCHANGE OF VACCINE PRODUCTS (Dose 1 and 2 Pfizer, Dose 3 Moderna) had resolved. At the time of the report, FEELING HOT (Felt warm briefly but drank water and that went away) and CHILLS (Mild chills for 2 days) had resolved and VACCINATION SITE PAIN (Injection site hurt), CHILLS (Slight chills) and PYREXIA (Temp of 100.1 F/ The toilet seat felt extra cool which probably means I was running a temperature) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Sep-2021, Body temperature: 100.1 (High) 100.1 F. No concomitant medications were provided. No treatment medications were provided. The patient received the third dose of the Moderna Covid-19 Vaccine at the same time as the High Dose Flu Shot. Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow-up received contains updated events- Feeling of warmth ,Temperature elevation, Vaccination site pain, Chills, Pyrexia and Chills

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Test Date: 20210901; Test Name: Body temperature; Result Unstructured Data: 100.1 F
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1704581

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

mild
Staat
OH
Alter
68,0
Geschlecht
F
Eingang
16.09.2021
Impfdatum
04.09.2021
Beginn
04.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pruritus Urticaria

Symptomtext

Hives all over body, very itchy. Saw the hives on day 1, still has the hives 12 days later.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1546111

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

mild
Staat
IL
Alter
66,0
Geschlecht
F
Eingang
11.08.2021
Impfdatum
08.08.2021
Beginn
09.08.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Injection site erythema Injection site swelling Injection site warmth Pyrexia

Symptomtext

Patient had sweeling, redness, hot to touch in left arm where she received Pneumovax23. She also reported a fever the evening of vaccine and called pharmacy next morning. Pharmacy referred her to Primary care who referred her to urgent care. Cephalexin 500mg and a Medrol Dospak was prescribed. The fever broke 8/9, swelling was down 8/10/21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension
Andere Medikamente
carvedilol 12.5mg, losartan 25mg
Allergien
none known
Vorherige Impfungen
-

VAERS 2554861

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

gering
Staat
CA
Alter
76,0
Geschlecht
M
Eingang
09.01.2023
Impfdatum
08.01.2023
Beginn
08.01.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

An expired dose of Fluzone HD was administered to a 76 year old male 1/8/23. Expiration date was 06/30/2022. Patient reported no adverse effects following administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1725811

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

gering
Staat
-
Alter
32,0
Geschlecht
F
Eingang
23.09.2021
Impfdatum
14.09.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Patient received vaccinations of Fluzone QIV NP that expired, with no adverse event; Pregnant woman received vaccinations of Fluzone QIV NP that expired on 30-Jun-2021, with no AE; Initial information regarding an unsolicited valid non-serious case was received from other Health Professional via Medical Information (Reference number- 00768512) and transmitted to Sanofi on 14-Sep-2021. This case involves a 32-year-old female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] after she received expired dose at 32 weeks of pregnancy, during third pregnancy trimester (expired product administered and exposure during pregnancy). Data regarding this pregnancy were received prospectively. The date of last menstrual period was reported as 06-Feb-2021. The estimated due date is 18-Nov-2021. The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication and family history were not provided. The patient had no previous pregnancy/ies. On 14-Sep-2021, the patient received a 0.5 mL first dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ702AA and expiry date: 30-Jun-2021) via intramuscular route in the right deltoid for prophylactic vaccination (expired product administered and exposure during pregnancy). It was an actual medication error case due to expired vaccine used and vaccine exposure during pregnancy (latency: same day). At the time of reporting, the patient experienced no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1718518

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

gering
Staat
PA
Alter
31,0
Geschlecht
F
Eingang
21.09.2021
Impfdatum
14.09.2021
Beginn
14.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Exposure during pregnancy No adverse event

Symptomtext

patient was administered an expired vaccine/ no AE; patient was administered vaccine during pregnent/ no AE; Initial information was received on 14-Sep-2021 regarding an unsolicited valid non-serious case received from a Physician via Regulatory Authority (Reference number- 00768515) and transmitted to Sanofi on 14-Sep-2021. This case involves a 31-year-old female patient who administered an expired INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] with no adverse event (expired product administered) during her pregnancy (Maternal exposure during pregnancy). Gestation period at onset was 45 weeks. Data regarding this pregnancy were received prospectively for example before pregnancy outcome was unknown. The date of last menstrual period was 12-Oct-2020 The estimated due date is 29-Sep-2021. Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. On 14-Sep-2021 patient received a 0.5 ml (total) of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [lot UJ702AA and expiry date 30-Jun-2021] via intramuscular route in right deltoid for prophylactic vaccination. It was reported,"4 patients in her office on 14SEP2021 received vaccinations of FLUZONE QIV NP that expired on 30JUN2021. Caller asked for information on how to proceed and whether or not these doses should be re-administered". It was a case of actual medication error due to Expired vaccine used and Maternal exposure during pregnancy (latency was on same day). Relevant prenatal testing after exposure was not reported. At the time of reporting, patient had no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1718517

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

gering
Staat
PA
Alter
30,0
Geschlecht
F
Eingang
21.09.2021
Impfdatum
14.09.2021
Beginn
14.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Exposure during pregnancy No adverse event

Symptomtext

patient was received an expired vaccine/ no AE; patient was administered vaccine during pregnent/ no AE; Initial information was received on 14-Sep-2021 regarding an unsolicited valid non-serious case received from a Physician via Medical Information (Reference number- 00768515) and transmitted to Sanofi on 14-Sep-2021. This case involves a 31-year-old female patient who administered an expired INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] with no adverse event (expired product administered) during her pregnancy (Maternal exposure during pregnancy). Gestation period at onset was 10 weeks. Data regarding this pregnancy were received prospectively for example before pregnancy outcome was unknown. The date of last menstrual period was 06-Jul-2021. The estimated due date is 12-Apr-2022. Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. On 14-Sep-2021, the patient received a 0.5 ml (total) dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [lot UJ702AA and expiry date 30-Jun-2021] via intramuscular route in the left deltoid for prophylactic vaccination. It was reported "4 patients in her office on 14SEP2021 received vaccinations of FLUZONE QIV NP that expired on 30JUN2021. Caller asked for information on how to proceed and whether or not these doses should be re-administered". It was a case of actual medication error due to Expired vaccine used and Maternal exposure during pregnancy (latency was on same day). Relevant prenatal testing after exposure was not reported. At the time of reporting, patient had no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1718516

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

gering
Staat
PA
Alter
34,0
Geschlecht
F
Eingang
21.09.2021
Impfdatum
14.09.2021
Beginn
14.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient was administered an expired vaccine/ no AE; Initial information was received on 14-Sep-2021 regarding an unsolicited valid non-serious case received from a Physician via Medical Information (GMI) (Reference number- 00768466) and transmitted to Sanofi on 14-Sep-2021. This case involves a 34-year-old female patient who administered an expired INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] with no adverse event (Expired product administered). Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. On 14-Sep-2021, the patient received a 0.5 ml (total) dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (Injection) [lot UJ702AA and expiry date 30-Jun-2021] via intramuscular route in right deltoid for prophylactic vaccination. It was reported, "Caller states that 4 patients in her office on 14SEP2021 received vaccinations of FLUZONE QIV NP that expired on 30JUN2021. Caller asked for information on how to proceed and whether or not these doses should be re-administered". It was a case of actual medication error due to Expired vaccine used (latency was on same day). At the time of reporting, patient had no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1696332

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

gering
Staat
MA
Alter
63,0
Geschlecht
U
Eingang
14.09.2021
Impfdatum
09.09.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

no adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
-
Vorherige Impfungen
-

VAERS 1542090

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ702AA

gering
Staat
HI
Alter
64,0
Geschlecht
F
Eingang
11.08.2021
Impfdatum
10.08.2021
Beginn
10.08.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

64 yo female patient came in for a flu shot. We processed her paperwork for regular dose Fluzone. The immunizer accidentally grabbed Fluzone HD from the refrigerator and administered it to the patient. The patient was informed of the error approximately 5 minutes after administration. She was informed to contact both us (the administering pharmacy) and her physician if she experiences any side effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-